The PE Ratio as of May 2025 (TTM) for Almirall, S.A. (LBTSF) is 150.17

According to Almirall, S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 150.17. This represents a change of 181.14% compared to the average of 53.41 of the last 4 quarters.

Almirall, S.A. (LBTSF) Historical PE Ratio (quarterly & annually)

How has LBTSF PE Ratio performed in the past?

The mean historical PE Ratio of Almirall, S.A. over the last ten years is 59.63. The current 150.17 PE Ratio has changed 25.08% with respect to the historical average. Over the past ten years (40 quarters), LBTSF's PE Ratio was at its highest in in the September 2023 quarter at 298.75. The PE Ratio was at its lowest in in the December 2021 quarter at -348.09.

Almirall, S.A. (LBTSF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Almirall, S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Almirall, S.A. (LBTSF) Average PE Ratio

How has LBTSF PE Ratio performed in the past?

The current PE Ratio of Almirall, S.A. (LBTSF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Almirall, S.A. (LBTSF) PE Ratio vs. Peers

How is LBTSF’s PE Ratio compared to its peers?

Almirall, S.A.’s PE Ratio is greater than RAMM Pharma Corp. (-0.16), greater than North Bud Farms Inc. (-0.00), greater than CanaQuest Medical Corp. (-0.17), greater than City View Green Holdings Inc. (-1.79), greater than Craftport Cannabis Corp. (-0.00), less than Ironwood Pharmaceuticals, Inc. (0), greater than Alkermes plc (-3.02), greater than Eagle Pharmaceuticals, Inc. (14.14), greater than ANI Pharmaceuticals, Inc. (0.54), greater than Aquestive Therapeutics, Inc. (-55.04), greater than Intra-Cellular Therapies, Inc. (-4.00), greater than Catalent, Inc. (-182.12), greater than Amphastar Pharmaceuticals, Inc. (-27.97), greater than Alvotech (8.13), greater than Assertio Holdings, Inc. (29.60), greater than Shuttle Pharmaceuticals Holdings, Inc. (-2.18), greater than Alimera Sciences, Inc. (-0.18), greater than Lifecore Biomedical, Inc. (-20.50), greater than Petros Pharmaceuticals, Inc. (-5.35), greater than null (-0.01),

Build a custom stock screener for Almirall, S.A. (LBTSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Almirall, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Almirall, S.A. (LBTSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Almirall, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.